| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/10/2003 | EP1341820A2 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 09/10/2003 | EP1341818A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/10/2003 | EP1341814A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/10/2003 | EP1341807A2 Interferon-alpha induced gene |
| 09/10/2003 | EP1341553A1 Silensed anti-cd28 antibodies and use thereof |
| 09/10/2003 | EP1341551A2 Treatment of posterior capsule opacification |
| 09/10/2003 | EP1054689B1 Strategically modified hepatitis b core proteins and their derivatives |
| 09/10/2003 | EP1007632A4 Isolation of bone and cartilage precursor cells |
| 09/10/2003 | EP0914613B1 Dp and e2f protein nuclear localisation signals and their use |
| 09/10/2003 | EP0736106B1 Methods of screening for beta-amyloid peptide production inhibitors |
| 09/10/2003 | EP0654092B1 Method for detecting pre-cancerous or cancerous cells using p90 and p53 antibodies or probes |
| 09/10/2003 | EP0594732B1 Humanized antibody against cd18 |
| 09/10/2003 | EP0575546B1 Cyclin d1 and its cdna |
| 09/10/2003 | CN1441844A Variable region of monoclonal antibody against HBV s-surface antigen and gene encoding same |
| 09/10/2003 | CN1441811A Anti-body capable to selectively detect prion PrPsc isoforms |
| 09/10/2003 | CN1441810A Soluble CTL A4 mutant molecules and use thereof |
| 09/10/2003 | CN1441677A Combined use of anti-cytokine antibodies or antagonists and anti-CD2O for treatment of B cell lymphoma |
| 09/10/2003 | CN1120847C (1-3)-beta-D-glucan-binding protein, antibody that recognizes said protein, and use of said protein and antibody |
| 09/09/2003 | US6617450 P-glycoproteins and uses thereof |
| 09/09/2003 | US6617435 Infiltrating a plant tissue with a buffer solution; subjecting plant tissue and buffer solution to a substantially vacuum environment; removing tissue from the buffer solution; centrifuging the tissue to remove interstitial fluid; |
| 09/09/2003 | US6617432 Useful as markers in diagnosing, monitoring the stage of malignancy and treating prostate cancer |
| 09/09/2003 | US6617430 Ataxin-2 binding proteins |
| 09/09/2003 | US6617429 Apoptosis inhibitory protein, gene encoding the protein and cDNA thereof |
| 09/09/2003 | US6617427 Capable of promoting tumor necrosis factor induced apoptosis; useful as targets for screening drugs that regulate-cell cycle progression and apoptosis; use in treating degenerative diseases and cancer |
| 09/09/2003 | US6617160 From mouse immunoglobulin, which inhibits binding of VEGF (vascular endothelial growth factor) to its receptor; use in diagnosis and treatment of solid tumors, cancer, rheumatoid arthritis, diabetic retinopathy and psoriasis |
| 09/09/2003 | US6617145 Enzymatic protein for use in treatment of thrombosis |
| 09/09/2003 | US6617135 Multiple cytokine protein complexes |
| 09/09/2003 | US6617129 Isolated nucleic acid; prostate-specific gene therapy method; diagnosis and treatment of prostate cancer |
| 09/09/2003 | US6617119 Monitoring sample for preferential proteins; evaluate protein configurations, hydrolyze protein, detect enzyme resistant protein, measure amount of defect related protein in sample |
| 09/09/2003 | US6617118 Monoclonal antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules |
| 09/09/2003 | US6617117 MAP kinases: polypeptides, polynucleotides and uses thereof |
| 09/09/2003 | US6617110 Cultured cell comprising a nucleic acid sequence, encoding the protein, that hybridizes to a polynucleotide of given sequence; use to determine if drug is cytotoxic; can use as anticarcinogenic agent |
| 09/09/2003 | US6617104 Predisposition to breast cancer by mutations at the ataxia-telangiectasia genetic locus |
| 09/09/2003 | US6617102 Screening for a bioactive agent capable of interfering with the binding of a protein; use in diagnosis and treatment of cancer |
| 09/09/2003 | US6616927 Processes for production of immunoglobulin A in milk |
| 09/09/2003 | US6616926 Methods of modulating lipid metabolism and storage |
| 09/09/2003 | US6615839 Surgical method for the delivery of saliva-borne antibodies to the blood stream for the treatment of infectious diseases |
| 09/09/2003 | CA2101648C Polysaccharide-protein conjugates |
| 09/06/2003 | CA2420829A1 Novel fusion protein of human igg1 heavy chain constant region and scfv antibody against venezuelan equine encephalitis virus |
| 09/04/2003 | WO2003073104A2 Diagnostic and therapeutic use of ma onconeuronal antigens for neurodegenerative diseases |
| 09/04/2003 | WO2003072829A1 Nanostructures containing pna joining or functional elements |
| 09/04/2003 | WO2003072804A2 Nanostructures containing pilin protein |
| 09/04/2003 | WO2003072803A2 Nanostructures containing antibody assembly units |
| 09/04/2003 | WO2003072800A2 Haemophilus adherence and penetration proteins |
| 09/04/2003 | WO2003072799A2 Brother of the regulator of imprinted sites (boris) |
| 09/04/2003 | WO2003072796A1 Reaction solution for cell-free protein synthesis, method of preparing the same and protein synthesis method using the same |
| 09/04/2003 | WO2003072781A1 Mite galectin |
| 09/04/2003 | WO2003072766A1 Anti-ccr5 antibody |
| 09/04/2003 | WO2003072740A2 Novel type-1 cytokine receptor glm-r |
| 09/04/2003 | WO2003072736A2 Reagents and treatment methods for autoimmune diseases |
| 09/04/2003 | WO2003072727A2 EGFRvIII SPECIFIC MONOCLONAL ANTIBODY AND EGFRvIII RIBOZYMES AND USE TO DETECT, TREAT OR PREVENT EGFRvIII ASSOCIATED CANCER |
| 09/04/2003 | WO2003072720A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 09/04/2003 | WO2003072719A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences |
| 09/04/2003 | WO2003072718A2 In situ induced antigen technology (isiat) for identification of polynucleotides expressed during infection or colonization |
| 09/04/2003 | WO2003072715A2 Gasp1: a follistatin domain containing protein |
| 09/04/2003 | WO2003072609A1 Tick chitinase |
| 09/04/2003 | WO2003072608A1 Anti-human tenascin monoclonal antibody |
| 09/04/2003 | WO2003072607A1 Monoclonal antibodies that are cross-reactive against bacterial collagen binding proteins |
| 09/04/2003 | WO2003072598A2 Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases |
| 09/04/2003 | WO2003072134A1 Diagnostics and remedies for interstitial pneumonia |
| 09/04/2003 | WO2003072068A2 Targeted immunotherapy of acute lymphoblastic leukemia (all) |
| 09/04/2003 | WO2003072063A2 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 09/04/2003 | WO2003072062A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 09/04/2003 | WO2003072045A2 Treatment and prevention of aids progression and methods of using same |
| 09/04/2003 | WO2003072040A2 Administration of agents for the treatment of inflammation |
| 09/04/2003 | WO2003072036A2 Treatment methods using anti-cd22 antibodies |
| 09/04/2003 | WO2003072035A2 Compositions and methods for the treatment of immune related diseases |
| 09/04/2003 | WO2003072017A2 Macromolecular conjugates and processes for preparing same |
| 09/04/2003 | WO2003071933A2 Novel compositions and methods for cancer |
| 09/04/2003 | WO2003064472A3 Treatment of ms with goat serum |
| 09/04/2003 | WO2003057006A3 Use of antibodies against the muc18 antigen |
| 09/04/2003 | WO2003053224A3 Novel compositions and methods for cancer |
| 09/04/2003 | WO2003051926A3 Anti-cd7 immunotoxin as fusion protein |
| 09/04/2003 | WO2003049704A3 Antibodies to treat cancer |
| 09/04/2003 | WO2003048334A3 Immunocytokines with modulated selectivity |
| 09/04/2003 | WO2003046566A3 Pedf biopolymer markers predictive of alzheimers disease |
| 09/04/2003 | WO2003046560A3 Self-assembly molecules |
| 09/04/2003 | WO2003046003A3 Plasma protease c1 biopolymer markers predictive of alzheimers disease |
| 09/04/2003 | WO2003045991A3 Complement c3 precursor biopolymer markers predictive of alzheimers disease |
| 09/04/2003 | WO2003029423A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/04/2003 | WO2003028625A3 Methods for screening monoclonal antibodies on heterogeneous antigen substrates |
| 09/04/2003 | WO2003022867A3 Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination against sag |
| 09/04/2003 | WO2003014151A3 Human secreted proteins, their encoding polynucleotides, and uses thereof |
| 09/04/2003 | WO2003009808A3 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 09/04/2003 | WO2003001212A3 A method for diagnosing a person having multiple sclerosis |
| 09/04/2003 | WO2002103016A3 Human tachykinin-related splice variants and compositions thereof |
| 09/04/2003 | WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 09/04/2003 | WO2002097395A3 P-cadherin as a target for anti-cancer therapy |
| 09/04/2003 | WO2002097048A3 ANTI-p40 IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES |
| 09/04/2003 | WO2002083858A8 Methods to inhibit viral replication |
| 09/04/2003 | WO2002083853A3 Method for enhancing the translation and expression of recombinant proteins |
| 09/04/2003 | WO2002079248A3 Mammalian alpha-helical protein-53 |
| 09/04/2003 | WO2002070703A3 Cell visual characteristic-modifying sequences |
| 09/04/2003 | WO2002064792A3 Molecules for disease detection and treatment |
| 09/04/2003 | WO2002060919A3 Molecules with extended half-lives, compositions and uses thereof |
| 09/04/2003 | WO2002053775A3 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 09/04/2003 | WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 09/04/2003 | WO2002046237A3 Humanized antibodies that recognize beta amyloid peptide |
| 09/04/2003 | WO2002036807A3 Compositions and methods relating to breast specific genes and proteins |
| 09/04/2003 | WO2002036770A3 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |